Home
→
Browsing by Author

Browsing by Author "Sorlí, Luisa"

Now showing items 1-9 of 9

Acute hematogenous periprosthetic hip infection by Gemella morbillorum, successfully treated with debridement, antibiotics and implant retention: A case report and literature review of osteoarticular Gemella morbillorum infections

Pardo-Pol, Albert; Pérez-Prieto, Daniel; Alier Fabrego, Albert; Ilzarbe Sánchez, Lucas; Sorlí, Luisa; Puig, Lluís; Martínez Díaz, Santos; Gómez Junyent, Joan (MDPI, 2022)

Gemella morbillorum is a facultative anaerobic, catalase-negative and non-spore forming Gram-positive cocci. It can be found as part of the normal oropharyngeal flora, in the gastrointestinal tract and the female genital ...
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study

Reyes, Carlen; Sorlí, Luisa; López Montesinos, Inmaculada; Duarte Salles, Talita, 1985- (BMJ Publishing Group, 2021)

Objective: To characterise patients with and without prevalent hypertension and COVID-19 and to assess adverse outcomes in both inpatients and outpatients. Design and setting: This is a retrospective cohort study using 15 ...
Clinical and economic impact of community-onset urinary tract infections caused by ESBL-producing Klebsiella pneumoniae requiring hospitalization in Spain: an observational cohort study

Rozenkiewicz, Dawid; Esteve Palau, Erika; Arenas-Miras, María Del Mar; Grau Cerrato, Santiago; Duran Jordà, Xavier, 1974-; Sorlí, Luisa; Montero, María Milagro; Horcajada Gallego, Juan Pablo (MDPI, 2021)

Objective: To analyze the clinical and economic impact of community-onset urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae requiring hospitalization. Methods: ...
Effectiveness of fosfomycin for the treatment of multidrug-resistant escherichia coli bacteremic urinary tract infections: a randomized clinical trial

Sojo-Dorado, Jesús; Sorlí, Luisa; REIPI-GEIRAS-FOREST group (American Medical Association, 2022)

Importance: The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected ...
Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients

Montero, Maria Milagro; Hardy-Werbin, Max; Gonzalez-Gallardo, Soledad; Torres, Erica; Rueda, Rebeca; Arenas-Miras, María Del Mar; Arietta-Aldea, Itziar; Castañeda, Silvia; Gómez Junyent, Joan; Gómez-Zorrilla, Silvia; Guerri-Fernandez, Robert; Sánchez-Martínez, Francesca; López Montesinos, Inmaculada; Pelegrín, Iván; Sendra, Elena; Sorlí, Luisa; Villar García, Judit; Bellosillo Paricio, Beatriz; Horcajada Gallego, Juan Pablo (Nature Research, 2023)

Tools for the evaluation of COVID-19 severity would help clinicians with triage decisions, especially the decision whether to admit to ICU. The aim of this study was to evaluate SeptiCyte RAPID, a host immune response assay ...
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model

Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque Pardos, Sònia; Sorlí, Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Ferrer Alapont, Lorena; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo (Nature Research, 2021)

Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time-dependent antimicrobial, prolonged infusion may help ...
Pharmacokinetics and pharmacodynamics of meropenem by extended or continuous infusion in low body weight critically ill patients

Luque Pardos, Sònia; Benítez-Cano, Adela; Larrañaga, Leire; Sorlí, Luisa; Navarrete Rouco, Maria Eugenia; Campillo Ambrós, Núria; Carazo Cordobés, Jesús; Ramos, Isabel; Adalia Bartolomé, Ramón; Grau Cerrato, Santiago (MDPI, 2021)

Background: Pathophysiological changes such as extreme body weights in critically ill patients with severe infections may alter the pharmacokinetics (PK) of antimicrobials, leading to treatment failure or toxicity. There ...
Rates and predictors of treatment failure in Staphylococcus aureus prosthetic joint infections according to different management strategies: A multinational cohort study-the ARTHR-IS study group

Espíndola, Reinaldo; Sorlí, Luisa; ARTHR-IS Group (Springer, 2022)

Introduction: Guidelines have improved the management of prosthetic joint infections (PJI). However, it is necessary to reassess the incidence and risk factors for treatment failure (TF) of Staphylococcus aureus PJI (SA-PJI) ...
Time-kill evaluation of antibiotic combinations containing ceftazidime-avibactam against extensively drug-resistant Pseudomonas aeruginosa and their potential role against ceftazidime-avibactam-resistant isolates

Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque, Sonia; Sorlí, Luisa; Campillo Ambrós, Núria; López Montesinos, Inmaculada; Padilla, Eduardo; Prim, Núria; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo (American Society for Microbiology, 2021)

Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective ...

Now showing items 1-9 of 9

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

Compliant to Partaking

Browsing by Author "Sorlí, Luisa"

Browsing by Author "Sorlí, Luisa"

Search DSpace

Browse

All of DSpace

My Account